-33%

est. 2Y upside i

HealthcareSeries A

Medication & support to beat opioid addiction from home

Rank

#3519

Sector

Digital Health

Est. Liquidity

~2Y

Data Quality

Data: Medium

With a probability-weighted expected return of -33% over 2 years and high bear-case probability, this equity grant offers limited upside and significant downside.

Last updated: July 3, 2026

Bull (10%)+62%

If DEA telehealth flexibilities become permanent and Ophelia achieves category leadership, exit multiple expands to 6x, yielding $419M exit despite 20% dilution.

Base (45%)-29%

Exit multiple converges to 3x, in line with public digital health comps, resulting in $210M exit value, but dilution and preference stack compress returns.

Bear (45%)-59%

Regulatory tightening or competition reduces multiple to 2x, exit value $140M, with severe preference overhang (36% of valuation) and dilution leading to near-total loss.

Est. time to liquidity~2.0 years

Preference Stack Risk

severe

Funding Intensity

18900%

Total preferred liquidation preference of $83.4M represents 36% of the $230M entry valuation.

Dilution Risk

high

With $44.1M revenue and moderate capital intensity, a new round could dilute existing holders by 20%+.

Secondary Liquidity

moderate

Recent secondary valuation at $230M suggests some liquidity for existing shares.

Other — 18 roles

View all 18 open roles at Ophelia →

Last updated: March 10, 2026

Questions to Ask at the Interview

Strategic questions based on Ophelia's data — designed to show you've done your homework.

  • 1

    “How would you defend against regulatory changes requiring in-person visits?”

  • 2

    “What is the unit economics of a patient and how does it scale?”

  • 3

    “What is the expected timeline to liquidity given the preference stack and funding history?”

Community

Valuation Sentiment

Our model estimates -33% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.